| Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 |
|---|---|---|---|---|---|---|
Expenses | ||||||
Research and development expenses | ||||||
10,691 | 7,437 | 10,995 | 10,591 | 7,073 | 6,332 | 3,407 |
Investment tax credits | ||||||
363 | 203 | 151 | 1,025 | 91 | 70 | 49 |
Research and development expense, net | ||||||
10,328 | 7,233 | 10,844 | 9,566 | 6,982 | 6,262 | 3,357 |
General and administrative expenses | ||||||
4,447 | 3,899 | 2,857 | 2,408 | 2,816 | 2,393 | 1,668 |
Interest income | ||||||
531 | 538 | 551 | 578 | 316 | 106 | 80 |
Financial expenses | ||||||
-3 | -27 | -40 | 2 | -29,415 | -14,677 | -36,347 |
Net loss before income taxes | ||||||
-14,248 | -10,621 | -13,190 | -11,393 | -38,899 | -23,226 | -41,292 |
Income tax expense | ||||||
528 | 146 | 40 | 395 | 106 | 97 | 44 |
Net loss and comprehensive loss | ||||||
-14,777 | -10,767 | -13,231 | -11,788 | -39,005 | -23,324 | -41,336 |
Basic and diluted loss per share (in dollars per share) | ||||||
-0.46 | -0.34 | -0.42 | 20.92 | -1.83 | -9.54 | -17.48 |
Weighted average number of outstanding basic and diluted shares (in shares) | ||||||
31,717 | 31,717 | 31,717 | 32,114 | 21,317 | 2,445 | 2,364 |